Emerging technologies are transforming the life sciences. In the past decade, researchers worldwide have embraced a multidisciplinary approach that combines biological techniques, elements, and systems with engineering concepts, empowered by rapidly growing global capacities to manage and analyze complex biological data and disruptive discoveries in gene editing. Current and future technologies in the biosciences – including cellular biotechnologies, synthetic biology, and genomic medicine – have the potential to transform research, medicine, and public health, with implications for the sciences, society, and security. MICB 805 is a graduate seminar that will introduce the biological basis, hope, and hype of these emerging technologies through the review of current technical and policy literature. Students will prepare a policy brief with recommendations for policies and/or regulatory frameworks to balance the benefits and risks of these emerging technologies for science and society.